सेरेब्रल टोक्सोप्लाज्मोसिस के लिए प्रथम-पंक्ति उपचार क्या है?

References

• Adjunctive corticosteroids (e.g., dexamethasone) should only be administered when clinically indicated to treat a mass effect associated with focal lesions or associated edema (BIII); discontinue as soon as clinically feasible.
• Antiseizure medications should be administered to patients with TE and associated seizures (AII) and continued through at least the period of acute treatment (BII); antiseizure medications should not be used as prophylaxis in patients without seizures (BII).
• Neurological improvement will occur by 14 days in over 90% of patients; if no improvement is seen by that time, other diagnoses should be considered.
• The radiologic goals for treatment include resolution of the lesion(s) in terms of size, contrast enhancement, and associated edema, although residual contrast-enhancing lesions may persist for prolonged periods, especially in people with HIV receiving ARVs.